首页> 外文期刊>Clinical Endocrinology >Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: Results from the German Conn's Registry
【24h】

Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: Results from the German Conn's Registry

机译:长期接受螺内酯治疗后自发性醛固酮增多症的缓解:德国Conn登记处的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Primary aldosteronism (PA) is mainly caused by aldosterone-producing adenoma and idiopathic bilateral adrenal hyperplasia (IHA). Recently, spontaneous resolution of IHA has been described. Objective: We aimed to determine the frequency of spontaneous remission of PA during long-term treatment with mineralocorticoid receptor (MR) antagonists. Design, setting and patients: Thirty-seven patients of the Munich PA registry with IHA treated by MR antagonists were investigated. The patients were identified retrospectively by chart review and prospectively assessed by clinical and biochemical means. Main outcome measures: Complete remission of IHA was defined as normal aldosterone to renin ratio (ARR), normal suppression test and normalization of hypokalaemia in the presence of normal blood pressure. Partial remission was defined as normalization of normal ARR, normal suppression test and normalization of hypokalaemia in the presence of persistent hypertension. Results: The mean period of MR antagonist treatment was 5.8 ± 0.7 years in the patients. We identified two of 37 (5.4%) patients with spontaneous remission: one with complete remission and one with partial remission. Conclusion: Remission of IHA in PA may occur in some patients after long-term mineralocorticoid antagonist treatment.
机译:背景:原发性醛固酮增多症(PA)主要由产生醛固酮的腺瘤和特发性双侧肾上腺增生(IHA)引起。近来,已经描述了IHA的自发解决。目的:我们旨在确定长期使用盐皮质激素受体(MR)拮抗剂治疗时PA自发缓解的频率。设计,背景和患者:调查了慕尼黑PA登记处的37例接受MR拮抗剂治疗的IHA患者。通过图表审查回顾性鉴定患者,并通过临床和生化手段进行前瞻性评估。主要预后指标:IHA的完全缓解定义为醛固酮与肾素的比率正常(ARR),正常抑制试验和在正常血压存在下低血钾正常化。部分缓解定义为在持续性高血压存在下正常ARR,正常抑制试验和低血钾正常化。结果:MR拮抗剂治疗的平均时间为5.8±0.7年。我们确定了37例(5.4%)自发缓解的患者中的2例:1例完全缓解,1例部分缓解。结论:长期接受盐皮质激素拮抗剂治疗的某些患者可能会发生PA中IHA的缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号